Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013 (2013), Article ID 130470, 5 pages
http://dx.doi.org/10.1155/2013/130470
Clinical Study

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

1Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
2Laboratory of Circulating Cancer Biomarker, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
3Department of Biostatistics, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
4Department of Medicine, Institut Gustave Roussy, 39 rue Desmoulins, 94805 Villejuif, France
5Department of Surgery, Institut Curie, 26 rue d'Ulm, 75005 Paris, France
6Department of Medical Oncology, Hôpital Saint Louis, 1 Avenue Vellefaux, 75011 Paris, France
7Université Paris Descartes, 15 rue de l'École de Médecine, 75006 Paris, France

Received 28 March 2013; Accepted 19 April 2013

Academic Editor: Claudio Luparello

Copyright © 2013 François-Clément Bidard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • François-Clément Bidard, Jordan Madic, Pascale Mariani, Sophie Piperno-Neumann, Aurore Rampanou, Vincent Servois, Nathalie Cassoux, Laurence Desjardins, Maud Milder, Isabelle Vaucher, Jean-Yves Pierga, Ronald Lebofsky, Marc-Henri Stern, and Olivier Lantz, “Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma,” International Journal of Cancer, vol. 134, no. 5, pp. 1207–1213, 2013. View at Publisher · View at Google Scholar
  • Michal Mego, and James M. Reuben, “Prognostic and Predictive Role of Circulating Tumor Cells in Breast Cancer,” Current Breast Cancer Reports, 2014. View at Publisher · View at Google Scholar
  • Justin Stebbing, Victoria Harding, Catherine E Urch, Thomas Kaier, Guy Schofield, Matthew Flook, Constantine Alifrangis, Anna-Mary Young, Jacqueline A Shaw, R Charles Coombes, and Jonathan Krell, “The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancy,” Future Oncology, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Sophie Seronie-Vivien, “Circulating tumor cells: a new challenge for laboratory medicine,” Annales de Biologie Clinique, vol. 72, no. 2, pp. 153–177, 2014. View at Publisher · View at Google Scholar
  • Nick Beije, Agnes Jager, and Stefan Sleijfer, “Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?,” Cancer Treatment Reviews, 2014. View at Publisher · View at Google Scholar
  • Massimiliano Bissolati, Maria Teresa Sandri, Giovanni Burtulo, Laura Zorzino, Gianpaolo Balzano, and Marco Braga, “Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Cristina Raimondi, Angela Gradilone, Giuseppe Naso, Nrico Cortesi, and Paola Gazzaniga, “Clinical utility of circulating tumor cell counting through CellSearch (R): the dilemma of a concept suspended in Limbo,” Oncotargets and Therapy, vol. 7, pp. 619–625, 2014. View at Publisher · View at Google Scholar
  • Jean-Yves Pierga, Thierry Petit, Christelle Levy, Jean-Marc Ferrero, Mario Campone, Joseph Gligorov, Florence Lerebours, Henri Roche, Thomas Bachelot, Emmanuelle Charafe-Jauffret, Jacques Bonneterre, Juana Hernandez, Francois-Clement Bidard, and Patrice Viens, “Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2(+) Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERL,” Clinical Cancer Research, vol. 21, no. 6, pp. 1298–1304, 2015. View at Publisher · View at Google Scholar
  • Wendy Onstenk, Jaco Kraan, Bianca Mostert, Mieke M. Timmermans, Ayoub Charehbili, Vincent T. H. B. M. Smit, Judith R. Kroep, Johan W. R. Nortier, Saskia van de Ven, Joan B. Heijns, LonnekeW. Kessels, HannekeW. M. van Laarhoven, Monique M. E. M. Bos, Cornelis J. H. van de Velde, Jan W. Gratama, Anieta M. Sieuwerts, John W. M. Martens, John A. Foekens, and Stefan Sleijfer, “Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadj,” Molecular Cancer Therapeutics, vol. 14, no. 3, pp. 821–827, 2015. View at Publisher · View at Google Scholar
  • Malgorzata Banys-Paluchowski, Natalia Krawczyk, Franziska Meier-Stiegen, and Tanja Fehm, “Circulating tumor cells in breast cancer—current status and perspectives,” Critical Reviews in Oncology/Hematology, 2015. View at Publisher · View at Google Scholar
  • M. Mego, and J.M. Reuben, “Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer,” Breast Diseases: A Year Book Quarterly, vol. 26, no. 4, pp. 311–314, 2015. View at Publisher · View at Google Scholar
  • Yan-Jun Lu, Peng Wang, Xiong Wang, Jing Peng, Yao-Wu Zhu, and Na Shen, “The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis.,” Oncotarget, vol. 7, no. 24, pp. 37361–37369, 2016. View at Publisher · View at Google Scholar
  • Sabine Kasimir-Bauer, Ann-Kathrin Bittner, Lisa König, Katharina Reiter, Thomas Keller, Rainer Kimmig, and Oliver Hoffmann, “Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy,” Breast Cancer Research, vol. 18, no. 1, 2016. View at Publisher · View at Google Scholar
  • Malgorzata Banys-Paluchowski, Natalia Krawczyk, and Tanja Fehm, “Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Jin Sun Lee, Mark Jesus M. Magbanua, and John W. Park, “Circulating tumor cells in breast cancer: applications in personalized medicine,” Breast Cancer Research and Treatment, 2016. View at Publisher · View at Google Scholar
  • Francois-Clement Bidard, Charlotte Proudhon, and Jean-Yves Pierga, “Circulating tumor cells in breast cancer,” Molecular Oncology, 2016. View at Publisher · View at Google Scholar
  • Andrea Nicolini, Paola Ferrari, and Michael J. Duffy, “Prognostic and Predictive Biomarkers in Breast Cancer: Past, Present and Future,” Seminars in Cancer Biology, 2017. View at Publisher · View at Google Scholar
  • Nathan A. Koonce, Mazen A. Juratli, Chengzhong Cai, Mustafa Sarimollaoglu, Yulian A. Menyaev, Judy Dent, Charles M. Quick, Ruud P.M. Dings, Dmitry Nedosekin, Vladimir Zharov, and Robert J. Griffin, “Local radiotherapy reduces circulating tumor cells and metastatic progression: Role of circulating cell detection in response to vascular damaging therapies,” Biochemical and Biophysical Research Communications, 2017. View at Publisher · View at Google Scholar
  • Wen-Ting Yan, Xiang Cui, Qing Chen, Ya-Fei Li, You-Hong Cui, Yan Wang, and Jun Jiang, “Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis,” Scientific Reports, vol. 7, pp. 43464, 2017. View at Publisher · View at Google Scholar
  • Sabine Riethdorf, Linda O'Flaherty, Claudia Hille, and Klaus Pantel, “Clinical applications of the CellSearch platform in cancer patients,” Advanced Drug Delivery Reviews, 2018. View at Publisher · View at Google Scholar